Chemotactic NO/H2S Nanomotors Realizing Cardiac Targeting of G-CSF against Myocardial Ischemia-Reperfusion Injury

ACS Nano. 2023 Jul 11;17(13):12573-12593. doi: 10.1021/acsnano.3c02781. Epub 2023 Jun 16.

Abstract

Recombinant granulocyte colony-stimulating factor (G-CSF), with a direct repair effect on injured cardiomyocytes against myocardial infarction ischemia-reperfusion-injury (IRI), displays a poor effect owing to the limited cardiac targeting efficacy. There are almost no reports of nanomaterials that deliver G-CSF to the IRI site. Herein, we propose a way to protect G-CSF by constructing one layer of nitric oxide (NO)/hydrogen sulfide (H2S) nanomotors on its outside. NO/H2S nanomotors with specific chemotactic ability to high expression of reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) at the IRI site can deliver G-CSF to the IRI site efficiently. Meanwhile, superoxide dismutase is covalently bound to the outermost part, reducing ROS at the IRI site through a cascade effect with NO/H2S nanomotors. The synergistic effect between NO and H2S on the effective regulation of the IRI microenvironment can not only avoid toxicity caused by excessive concentration of a single gas but also reduce inflammation level and relieve calcium overload, so as to promote G-CSF to play a cardioprotective role.

Keywords: hydrogen sulfide; ischemia-reperfusion injury; nanomotors; nitric oxide; targeted delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Granulocyte Colony-Stimulating Factor
  • Humans
  • Hydrogen Sulfide* / pharmacology
  • Myocardial Reperfusion Injury* / drug therapy
  • Myocardial Reperfusion Injury* / metabolism
  • Myocytes, Cardiac / metabolism
  • Nitric Oxide
  • Reactive Oxygen Species

Substances

  • Nitric Oxide
  • Reactive Oxygen Species
  • Hydrogen Sulfide
  • Granulocyte Colony-Stimulating Factor